Further to an earlier posting about Merck and Elsevier combining on a fake journal, Elsevier now acknowledges that there were six "sponsored article publications."
Elsevier Published Six Fake Journals
May 8, 2009
Share this post
2 Comments
![Law Bytes](https://www.michaelgeist.ca/wp-content/uploads/2019/12/Project.png)
Law Bytes
Episode 210: Meredith Lilly on the Trade Risks Behind Canada’s Digital Services Tax and Mandated Streaming Payments
byMichael Geist
![Episode 210: Meredith Lilly on the Trade Risks Behind Canada’s Digital Services Tax and Mandated Streaming Payments](https://www.michaelgeist.ca/wp-content/uploads/2019/12/Project.png)
July 15, 2024
Michael Geist
June 24, 2024
Michael Geist
Search Results placeholder
Recent Posts
The Law Bytes Podcast, Episode 210: Meredith Lilly on the Trade Risks Behind Canada’s Digital Services Tax and Mandated Streaming Payments
Abandoning Institutional Neutrality: Why the University of Windsor Encampment Agreements Constrain Academic Freedom and Freedom of Expression
The Law Bytes Podcast, Episode 209: Peter Menzies on Why the Canadian News Sector is Broken and How to Fix It
Why the University of Windsor Encampment Agreement Violates Antisemitism and Academic Freedom Standards
Know When to Fold Em: The Big Risk Behind Canada’s Digital Services Tax Bet
Use bugmenot to read the article
If you do not want to register just to read an article, use bugmenot.com to enter the-scientist site.
Sick and tired of walled gardens like Elsevier? Support Science Commons
http://sciencecommons.org/about/
Quote:
There are petabytes of research data being produced in laboratories around the world, but the best web search tools available can’t help us make sense of it. Why? Because more stands between basic research and meaningful discovery than the problem of search.
Many scientists today work in relative isolation, left to follow blind alleys and duplicate existing research. Data are balkanized — trapped behind firewalls, locked up by contracts or lost in databases that can’t be accessed or integrated. Materials are hard to get — universities are overwhelmed with transfer requests that ought to be routine, while grant cycles pass and windows of opportunity close. It’s not uncommon for research sponsors to invest hundreds of millions of dollars in critically important efforts like drug discovery, only to see them fail.
The consequences in many cases are no less than tragic. The time it takes to go from identifying a gene to developing a drug currently stands at 17 years — forever, for people suffering from disease.